DUBLIN--(BUSINESS WIRE)--The "Electrophoresis Market by Product (Gel Electrophoresis (1D & 2D Gel Electrophoresis, Agarose, PAGE), Capillary Electrophoresis (CZE, CGE, Isoelectric Focusing), Reagents, Imaging), Application (Research, Diagnostics), and End User - Global Forecast to 2025" report has been added to ResearchAndMarkets.com's offering.
The global electrophoresis market is expected to reach USD 3.59 billion by 2025 from USD 2.68 billion in 2020, at a CAGR of 6.0% during the forecast period.
The electrophoresis market is projected to grow at a CAGR of 6.0% during the forecast period.
The rising incidence of cancer, infectious diseases, and genetic disorders; growth in funding for research on genomic, proteomic, and electrophoresis techniques; the growing number of industry-academia research collaborations; growing use of capillary electrophoresis with mass spectroscopy; the increasing use of next-generation sequencing; and rise in the number of clinical, forensic, and research laboratories are factors driving the growth of the electrophoresis market. Additionally, the growth in emerging markets, increasing demand for personalized medicine, and a shift from plant-derived to genome-based drug discovery are also expected to provide significant growth opportunities for market players during the forecast period.
The software segment is expected to grow at the highest rate during the forecast period.
Based on products, the electrophoresis market is segmented into electrophoresis reagents, electrophoresis systems, gel documentation systems, and software. The software segment is projected to witness the highest growth in the electrophoresis market during the forecast period. This can be attributed to the increasing use of software solutions for data acquisition, quantization, and analysis. These solutions offer the advantage of the ease of use in tandem with gel documentation systems, along with the easy storage of data.
The diagnostics segment is expected to grow at the highest rate during the forecast period.
Based on application, the electrophoresis market is segmented into research, diagnostics, and quality control & process validation. The diagnostics segment is projected to witness the highest growth in the electrophoresis market during the forecast period. This is due to the increasing use of electrophoretic techniques in clinical diagnostics tests such as haemoglobin testing, multiple myeloma testing, blood alcohol measurement, and testosterone level measurements. Along with the use in assessing protein expression profiles and disease-specific biomarkers for disease identification is aiding the rapid growth of this segment.
The hospitals & diagnostic centers segment is expected to grow at the highest CAGR during the forecast period.
Based on end-users, the electrophoresis market is segmented into academic & research institutes, hospitals & diagnostic centers, pharmaceutical & biotechnology companies, and other end-users (CROs, forensic laboratories, and food testing laboratories). The hospitals & diagnostic centers segment is projected to witness the highest growth rate during the forecast period. The growing prevalence of immunodeficiency diseases and the rising incidence of serum protein disorders (such as liver diseases) are expected to drive the utilization of electrophoresis systems in this end-user segment during the forecast period. This can be attributed to the increasing use of electrophoresis in the analysis of plasma, enzymes (ALP, LDH, and CK), proteins, urine, lipoproteins, haemoglobin, serum, and cerebrospinal fluids.
The APAC is projected to witness the highest growth during the forecast period.
Even though North America is expected to account for the largest share of the global electrophoresis market in 2019, APAC is expected to witness the highest CAGR during the forecast period. Factors such as the increasing investments by governments and industries, growing biotechnology research in these regions, and rising awareness about personalized therapeutics are expected to drive the growth of the market during the forecast period. Furthermore, the increasing focus on the Asia Pacific market due to their low-cost manufacturing advantage also provides growth opportunities for manufacturers. The key players in this market have shifted their focus to the emerging economies in these regions, focusing on expansions and acquisitions in order to garner a greater market s
- Growth in Funding For Proteomic & Genomic Research And Electrophoresis Techniques
- A Growing Number of Industry-Academia Research Collaborations
- The Growing Use of Ngs And Declining Cost of DNA Sequencing
- Growth in the Number of Clinical, Forensic, And Research Laboratories
- Rising Incidence of Cancer, Infectious Diseases, & Genetic Disorders
- Growing Prominence of Nanoproteomics
- Presence of Alternative Technologies Offering Better Efficiency & Results
- Time-Consuming Operations & Limited Sample Analysis
- High Growth Opportunities in Emerging Countries
- Increasing Demand For Personalized Medicine
- Shift from Plant-Based to Genome-Based Drug Discovery
- Safety Concerns Associated With Electrophoresis Reagents
- Bio-Rad Laboratories
- Thermo Fisher Scientific
- Danaher Corporation
- Agilent Technologies
- Ge Healthcare
- Merck Kgaa
- Qiagen N.V.
- Shimadzu Corporation
- Harvard Bioscience, Inc.
- Sebia Group
- Takara Bio
- C.B.S Scientific Company, Inc. (4Basebio)
- Helena Laboratories
- Syngene (Synoptics Group)
- Vwr International, Llc (Avantor)
- Teledyne Technologies
- Tbg Diagnostics Ltd.
- Analytik Jena (Endress+Hauser)
For more information about this report visit https://www.researchandmarkets.com/r/y1k6yw